Dr Lalchandani Labs Ltd - 541299 - Outcome Of Board Meeting
Outcome Of Board Meeting13-11-2020
Dr Lalchandani Labs Ltd - 541299 - Board Meeting Intimation for Board Meeting Intimation For Notice Of Board Meeting To Consider Un-Audited Financial Results For The Half Year Ending 30Th September 2020.
Dr Lalchandani Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve Dr Lalchandani Labs Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2020 ,inter alia, to consider and approve -Unaudited Financial Results of the Company for the half year ended 30th September 2020 along with Limited Review report. -Any other Business matter, with the permission of the Chair.06-11-2020
Dr Lalchandani Labs Ltd - 541299 - Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30Th September, 2020
Certificate Issued In Compliance Of Regulation 40(9) Of The Provision Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015 For The Half Year Ended 30th September, 2020.26-10-2020
Dr Lalchandani Labs Ltd - 541299 - Shareholding for the Period Ended September 30, 2020
Dr Lalchandani Labs Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2020. For more details, kindly Click here20-10-2020
Dr Lalchandani Labs Ltd - 541299 - Compliance Certificate For The Period Ended 30Th September, 2020.
Compliance Certificate For The Period Ended 30th September, 2020.13-10-2020
Dr Lalchandani Labs Ltd - 541299 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulation, 2018 for the Quarter ended September 30, 2020.13-10-2020
Dr Lalchandani Labs Ltd - 541299 - Statement Of Investor Complaints For The Quarter Ended September 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- SWATI PODDARDesignation :- Company Secretary and Compliance Officer12-10-2020
Dr Lalchandani Labs Ltd - 541299 - Clarification
With reference to Movement in Price, Dr Lalchandani Labs Ltd has submitted to BSE a copy of Clarification is enclosed.09-10-2020
Dr Lalchandani Labs Ltd - 541299 - Clarification sought from Dr Lalchandani Labs Ltd
The Exchange has sought clarification from Dr Lalchandani Labs Ltd on October 9, 2020, with reference to Movement in Price.The reply is awaited.09-10-2020
Dr Lalchandani Labs Ltd - 541299 - Closure of Trading Window
CLOSURE OF TRADING WINDOW INTIMATION IN TERMS OF SEBI (PROHIBITION OF INSIDER TRADING) REGULATIONS, 2015.30-09-2020